Literature DB >> 25462818

C-type lectin like receptor 2 (CLEC-2) signals independently of lipid raft microdomains in platelets.

Bhanu Kanth Manne1, Rachit Badolia1, Carol A Dangelmaier1, Satya P Kunapuli2.   

Abstract

C-type lectin like receptor 2 (CLEC-2) has been reported to activate platelets through a lipid raft-dependent manner. Secreted ADP potentiates CLEC-2-mediated platelet aggregation. We have investigated whether the decrease in CLEC-2-mediated platelet aggregation, previously reported in platelets with disrupted rafts, is a result of the loss of agonist potentiation by ADP. We disrupted platelet lipid rafts with methyl-β-cyclodextrin (MβCD) and measured signaling events downstream of CLEC-2 activation. Lipid raft disruption decreases platelet aggregation induced by CLEC-2 agonists. The inhibition of platelet aggregation by the disruption of lipid rafts was rescued by the exogenous addition of epinephrine but not 2-methylthioadenosine diphosphate (2MeSADP), which suggests that lipid raft disruption effects P2Y12-mediated Gi activation but not Gz. Phosphorylation of Syk (Y525/526) and PLCγ2 (Y759), were not affected by raft disruption in CLEC-2 agonist-stimulated platelets. Furthermore, tyrosine phosphorylation of the CLEC-2 hemi-ITAM was not effected when MβCD disrupts lipid rafts. Lipid rafts do not directly contribute to CLEC-2 receptor activation in platelets. The effects of disruption of lipid rafts in in vitro assays can be attributed to inhibition of ADP feedback that potentiates CLEC-2 signaling.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lipid rafts; P2Y12; Platelet activation; Platelets; Signal transduction

Mesh:

Substances:

Year:  2014        PMID: 25462818      PMCID: PMC4289638          DOI: 10.1016/j.bcp.2014.11.005

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  46 in total

1.  Functional interaction between purinergic receptors: effect of ligands for A2A and P2Y12 receptors on P2Y1 receptor function.

Authors:  Tokiko Suzuki; Yutaro Obara; Takahiro Moriya; Hiroyasu Nakata; Norimichi Nakahata
Journal:  FEBS Lett       Date:  2011-11-10       Impact factor: 4.124

2.  The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.

Authors:  J Liu; T I Pestina; M C Berndt; S A Steward; C W Jackson; T K Gartner
Journal:  J Thromb Haemost       Date:  2004-12       Impact factor: 5.824

3.  The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.

Authors:  J C Spalton; J Mori; A Y Pollitt; C E Hughes; J A Eble; S P Watson
Journal:  J Thromb Haemost       Date:  2009-04-24       Impact factor: 5.824

Review 4.  Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI.

Authors:  Y Ozaki; K Suzuki-Inoue; O Inoue
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

5.  Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation.

Authors:  T M Quinton; S Kim; J Jin; S P Kunapuli
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

6.  Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling.

Authors:  Katsue Suzuki-Inoue; David Tulasne; Yang Shen; Teresa Bori-Sanz; Osamu Inoue; Stephanie M Jung; Masaaki Moroi; Robert K Andrews; Michael C Berndt; Steve P Watson
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

Review 7.  Novel platelet activation receptor CLEC-2: from discovery to prospects.

Authors:  K Suzuki-Inoue; O Inoue; Y Ozaki
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

8.  Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells.

Authors:  Taro Hitosugi; Moritoshi Sato; Kazuki Sasaki; Yoshio Umezawa
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

9.  CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis.

Authors:  Frauke May; Ina Hagedorn; Irina Pleines; Markus Bender; Timo Vögtle; Johannes Eble; Margitta Elvers; Bernhard Nieswandt
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

Review 10.  P2 receptors and platelet activation.

Authors:  Satva P Kunapuli
Journal:  ScientificWorldJournal       Date:  2002-02-13
View more
  2 in total

Review 1.  Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies.

Authors:  J J Shatzel; S R Olson; D L Tao; O J T McCarty; A V Danilov; T G DeLoughery
Journal:  J Thromb Haemost       Date:  2017-03-27       Impact factor: 5.824

2.  Control of Platelet CLEC-2-Mediated Activation by Receptor Clustering and Tyrosine Kinase Signaling.

Authors:  Alexey A Martyanov; Fedor A Balabin; Joanne L Dunster; Mikhail A Panteleev; Jonathan M Gibbins; Anastasia N Sveshnikova
Journal:  Biophys J       Date:  2020-04-29       Impact factor: 4.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.